Strategies for Addressing Resistance and Off-Target Toxicity in Antibody-Drug ConjugatesFebruary 24, 2026
DNA & Genetics Strategies for Addressing Resistance and Off-Target Toxicity in Antibody-Drug ConjugatesBy adminFebruary 24, 20260 The U.S. Food and Drug Administration’s approvals of Enhertu for various metastatic breast cancers last year sparked renewed interest in…
